These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36747030)
1. Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage. Amirzadeh N; Moghadam A; Niazi A; Afsharifar A Sci Rep; 2023 Feb; 13(1):2091. PubMed ID: 36747030 [TBL] [Abstract][Full Text] [Related]
2. Expression of a Recombinant Anti-HIV and Anti-Tumor Protein, MAP30, in Nicotiana tobacum Hairy Roots: A pH-Stable and Thermophilic Antimicrobial Protein. Moghadam A; Niazi A; Afsharifar A; Taghavi SM PLoS One; 2016; 11(7):e0159653. PubMed ID: 27459300 [TBL] [Abstract][Full Text] [Related]
3. MAP30 and luffin-α: Novel ribosome-inactivating proteins induce plant systemic resistance against plant viruses. Wei Z; Yang L; Liu W; Xu X; Ran M; Jin Y; Sun X Pestic Biochem Physiol; 2023 Apr; 191():105342. PubMed ID: 36963924 [TBL] [Abstract][Full Text] [Related]
4. Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity. Chen WW; Zhang HR; Huang ZG; Zhou ZY; Lou QW; Jiang XY; Zhu ZH Protein Expr Purif; 2021 Sep; 185():105893. PubMed ID: 33933613 [TBL] [Abstract][Full Text] [Related]
5. Recombinant expression and purification of a MAP30-cell penetrating peptide fusion protein with higher anti-tumor bioactivity. Lv Q; Yang XZ; Fu LY; Lu YT; Lu YH; Zhao J; Wang FJ Protein Expr Purif; 2015 Jul; 111():9-17. PubMed ID: 25797209 [TBL] [Abstract][Full Text] [Related]
6. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol. Meng Y; Liu S; Li J; Meng Y; Zhao X Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682 [TBL] [Abstract][Full Text] [Related]
7. Ribosome-inactivating Protein MAP30 Isolated from Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636 [TBL] [Abstract][Full Text] [Related]
8. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Puri M; Kaur I; Kanwar RK; Gupta RC; Chauhan A; Kanwar JR Curr Mol Med; 2009 Dec; 9(9):1080-94. PubMed ID: 19747115 [TBL] [Abstract][Full Text] [Related]
9. The type-1 and type-2 ribosome-inactivating proteins from Iris confer transgenic tobacco plants local but not systemic protection against viruses. Vandenbussche F; Peumans WJ; Desmyter S; Proost P; Ciani M; Van Damme EJ Planta; 2004 Dec; 220(2):211-21. PubMed ID: 15278456 [TBL] [Abstract][Full Text] [Related]
10. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro. Zhu F; Zhang P; Meng YF; Xu F; Zhang DW; Cheng J; Lin HH; Xi DH Planta; 2013 Jan; 237(1):77-88. PubMed ID: 22983699 [TBL] [Abstract][Full Text] [Related]
11. [Expression of recombinant ribosome inactivating protein MAP30 in E.coli and its biological activity]. Zhang LL; Ding Q; Zhan JB Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):264-71. PubMed ID: 20544988 [TBL] [Abstract][Full Text] [Related]
12. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070 [TBL] [Abstract][Full Text] [Related]
13. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells. Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785 [TBL] [Abstract][Full Text] [Related]
14. Α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Fan X; He L; Meng Y; Li G; Li L; Meng Y Mol Med Rep; 2015 May; 11(5):3553-8. PubMed ID: 25573293 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024 [TBL] [Abstract][Full Text] [Related]
16. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L. Meng Y; Lin S; Liu S; Fan X; Li G; Meng Y PLoS One; 2014; 9(7):e101998. PubMed ID: 25003606 [TBL] [Abstract][Full Text] [Related]
17. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII. Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182 [TBL] [Abstract][Full Text] [Related]
18. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro. Bourinbaiar AS; Lee-Huang S Biochem Biophys Res Commun; 1996 Feb; 219(3):923-9. PubMed ID: 8645280 [TBL] [Abstract][Full Text] [Related]
20. Studies on the anti-mitogenic, anti-phage and hypotensive effects of several ribosome inactivating proteins. Wang HX; Ng TB Comp Biochem Physiol C Toxicol Pharmacol; 2001 Mar; 128(3):359-66. PubMed ID: 11255109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]